Rare diseases
Investigational molecules
Locations
Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
FranceStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
FranceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
FranceStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
FranceStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
FranceLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FranceStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
